SCI Cancer Innovation Award

Congratulations to the projects selected for funding beginning September 2019

SCI Cancer Innovation Award

  • “Reprogramming Cancer Cells into Antigen Presenting Cells for Cancer Vaccination”; Ravi Majeti, MD, PhD; Paul Wender, PhD; Bob Weymouth, PhD
  • “Identification of Genetic Mutations in Patients With Multiple Primary Melanomas”; Kavita Sarin, MD, PhD; Susan Swetter, MD; Justin Ko, MD, MBA; Shaundra Eichstadt, MD
  • “Pilot study to improve survivorship care related to fertility and family-building after cancer”; Catherine Benedict, PhD; Lidia Schapira, MD; David Spiegel, MD; Jonathan Berek, MD; Allison Kurian, MD; Rubin Alvero, MD; Pamela Simon, NP
  • “A Surgical Window of Opportunity Trial Evaluating a Single Dose of Dostarlimab (Anti-PD-1) on Gestational Trophoblastic Neoplasia as a Model of Immune Marker Response”; Elisabeth Diver, MD

SCI Pancreatic Cancer Innovation Award

  •  “Early detection of pancreas cancers through multi-omic circulating tumor DNA profiling”; Daniel King, MD, PhD; Ash Alizadeh, MD, PhD      
  • “Development of a novel immunocompetent and physiologically-relevant mouse model for human pancreatic cancer”; Hiro Nakauchi, MD, PhD     

Stanford Women’s Cancer Center Innovation Award

  • “Profiling and Optimizing Ovarian Cancer Immunotherapy Responses in Patient-Derived Organoid Cultures”; Calvin Kuo, MD, PhD; Brooke Howitt, MD; Amer Karam, MD
  •  “Soluble CA-125 in Ovarian Cancer: Functional Implications and Therapeutic Targeting”; Venkatesh Krishnan, PhD; Oliver Dorigo, MD, PhD; Carolyn Bertozzi, PhD
  • “B7-H3 Targeted Microbubble Imaging for Early Breast Cancer Detection in the Radiographically Dense Breast”; Jeremy Dahl, PhD; Ramasamy Paulmurugan, PhD; Amalie Lutz, MD

SCI Nodal Grant Award

The SCI offers a new funding mechanism, which aims to catalyze the planning and execution of multi-PI grants from the National Cancer Institute, including R01s and P01s.  We are pleased to announce our inaugural recipient of this new award.

  • Systems Biology Approach to Dissecting Gamma-Delta T/NK Cell Cytotoxic Antitumor Networks”; Andrew Gentles, PhD; John Sunwoo, MD; Yueh-Hsiu Chien, PhD

SCI Cancer Innovation Award

The Stanford Cancer Institute’s (SCI) mission is to reduce cancer mortality and improve cancer care through comprehensive programs of cancer research, prevention, treatment, education and outreach. To achieve its mission, the leadership and members relentlessly pursue multiple strategic aims which include fostering interdisciplinary basic cancer research, translating scientific discovery into clinical research and optimal patient care, developing improved approaches to the prevention, early detection, precise diagnosis and effective treatment of cancer, and improving the cancer patient experience by developing and validating innovative initiatives in patient-centered care.